Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 17.07
-0.06 (-0.35%)
May 8, 2026, 3:00 PM CST
SHA:601607 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,809 | 5,725 | 4,553 | 3,768 | 5,617 | 5,093 |
Depreciation & Amortization | 2,734 | 2,734 | 2,419 | 2,187 | 2,222 | 2,140 |
Other Amortization | 327.61 | 327.61 | 192.33 | 192.33 | 195.59 | 186.89 |
Loss (Gain) From Sale of Assets | -157.15 | -157.15 | -187.97 | -92.48 | -1,439 | -58.29 |
Asset Writedown & Restructuring Costs | 1,037 | 1,037 | 448.52 | 70.65 | 322.39 | 88.98 |
Loss (Gain) From Sale of Investments | -194.83 | -194.83 | -128.89 | -383.74 | 30.06 | 204.41 |
Provision & Write-off of Bad Debts | 472.91 | 472.91 | 255.56 | 254.34 | 276.33 | -54.29 |
Other Operating Activities | 563.95 | -545.99 | 2,622 | 3,579 | 2,196 | 860.27 |
Change in Accounts Receivable | -3,669 | -3,669 | -4,041 | -6,432 | -10,081 | -6,156 |
Change in Inventory | -5,197 | -5,197 | -2,298 | -2,304 | -7,112 | -3,201 |
Change in Accounts Payable | 5,048 | 5,048 | 2,103 | 4,586 | 12,645 | 5,793 |
Operating Cash Flow | 7,349 | 6,154 | 5,827 | 5,232 | 4,743 | 5,061 |
Operating Cash Flow Growth | -19.21% | 5.61% | 11.39% | 10.29% | -6.28% | -26.05% |
Capital Expenditures | -2,283 | -2,326 | -2,401 | -2,971 | -2,685 | -4,119 |
Sale of Property, Plant & Equipment | 198.77 | 105.15 | 244.66 | 179.15 | 160.34 | 190.9 |
Cash Acquisitions | -261.65 | -280.31 | -85.29 | -357.08 | -84.33 | -1,153 |
Divestitures | 26.95 | 40.22 | - | 0.5 | 106.8 | -1,454 |
Investment in Securities | -1,447 | -2,042 | 1,338 | -436.23 | -10,486 | -86.68 |
Other Investing Activities | 469.54 | 520.61 | 1,320 | 1,092 | 514.75 | 606.31 |
Investing Cash Flow | -3,296 | -3,982 | 415.98 | -2,492 | -12,473 | -6,016 |
Short-Term Debt Issued | - | 65.03 | 137.37 | 163.6 | 363.04 | 29.26 |
Long-Term Debt Issued | - | 69,324 | 73,925 | 79,193 | 63,644 | 56,547 |
Total Debt Issued | 69,527 | 69,389 | 74,063 | 79,357 | 64,008 | 56,576 |
Short-Term Debt Repaid | - | -197.58 | -730.71 | -1,325 | -394.85 | -329.58 |
Long-Term Debt Repaid | - | -71,031 | -70,845 | -73,120 | -60,557 | -53,003 |
Total Debt Repaid | -74,728 | -71,229 | -71,575 | -74,445 | -60,952 | -53,333 |
Net Debt Issued (Repaid) | -5,201 | -1,840 | 2,487 | 4,912 | 3,055 | 3,243 |
Issuance of Common Stock | - | 7.38 | 86.2 | 106.42 | 13,982 | - |
Common Dividends Paid | -3,040 | -2,800 | -3,604 | -3,981 | -3,094 | -2,676 |
Other Financing Activities | -1,123 | -1,019 | -833.78 | -805.36 | -1,805 | 998.55 |
Financing Cash Flow | -9,364 | -5,652 | -1,864 | 231.85 | 12,139 | 1,566 |
Foreign Exchange Rate Adjustments | -15.93 | -3.12 | 2.16 | -5.58 | -12.44 | -50.32 |
Net Cash Flow | -5,327 | -3,483 | 4,381 | 2,966 | 4,396 | 561.06 |
Free Cash Flow | 5,066 | 3,828 | 3,426 | 2,261 | 2,058 | 942.55 |
Free Cash Flow Growth | -25.91% | 11.73% | 51.55% | 9.83% | 118.40% | -75.42% |
Free Cash Flow Margin | 1.76% | 1.35% | 1.24% | 0.87% | 0.89% | 0.44% |
Free Cash Flow Per Share | 1.37 | 1.03 | 0.93 | 0.61 | 0.59 | 0.33 |
Cash Income Tax Paid | 7,943 | 7,484 | 7,170 | 7,384 | 7,599 | 6,239 |
Levered Free Cash Flow | -1,207 | -2,706 | 2,496 | -1,069 | -595.85 | -1,374 |
Unlevered Free Cash Flow | -213.7 | -1,652 | 3,656 | 108.92 | 459.95 | -425.52 |
Change in Working Capital | -3,245 | -3,245 | -4,346 | -4,345 | -4,680 | -3,399 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.